Contemporary Conversations in Retinopathy of Prematurity

Faruk Orge, MD, and Darius Moshfeghi, MD, review today's top questions in the treatment of retinopathy of prematurity.

Videos From Regeneron

Decision Factors in managing patients with ROP

Faruk Orge, MD; and Darius Moshfeghi, MD

ICROP Classification and ROP Treatment Guidelines

Faruk Orge, MD; and Darius Moshfeghi, MD

Additional Considerations for Treating ROP

Faruk Orge, MD; Darius Moshfeghi, MD

About Regeneron

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, Regeneron's unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in Regeneron's laboratories.

Visit us online: regeneron.com

Follow Regeneron